Seeking Alpha

Seeking Alpha moves stocks

  • Tonix Pharmaceuticals (TNXP +8.3%) continues a big run after SA Pro's Joe Springer argues its TNX-102 SL drug for treatment of fibromyalgia and Post Traumatic Stress Disorder makes the stock one of the most undervalued in the market and a potential multi-bagger.
  • Management's "Celgene Contingency" attitude might prevent a quick takeover by a potential marketing partner, but that may be to the long-term benefit of shareholders, says Springer, reminding Celgene also fended away offers and a decade later is a $60B company.
Comments (8)
  • You da man Joe!!
    2 Dec 2013, 07:01 PM Reply Like
  • Thank you Jeff! And thank you for suggesting Tonix in the first place!
    2 Dec 2013, 07:28 PM Reply Like
  • I love you guys...... ;)


    A nice tonic for what ails you! TNXP


    Seeking Alpha exposes the market mispricing a stock!


    2 Dec 2013, 08:02 PM Reply Like
  • lol.. This was quite a rare find and I agree, the market had its eye off of the ball on TNXP. That doesnt happen very often so enjoy it!!
    2 Dec 2013, 08:08 PM Reply Like
  • @joe what is your target price and do you think its still a decent entry point ? ( I initiated a position around 4.2 and added a little to it last week )
    2 Dec 2013, 10:44 PM Reply Like
  • Valuation is laid out pretty clearly in the article. It'll be up in an hour and a half. I'd say you have a great entry point..
    3 Dec 2013, 09:10 AM Reply Like
  • New Bee,


    I believe you have a lot of safety under 10$. I would scale in here.




    3 Dec 2013, 09:54 AM Reply Like
  • @kenser @sheldond


    thanks :)
    3 Dec 2013, 11:18 PM Reply Like
DJIA (DIA) S&P 500 (SPY)